| content | ||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
Verdamicin
|
|
| Systematic (IUPAC) name | |
| (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[ [(2S,3R)-3-amino-6-[(1S)-1-aminoethyl]- 3,4-dihydro-2H-pyran-2-yl]oxy]- 2-hydroxycyclohexyl]oxy-5-methyl- 4-methylaminooxane-3,5-diol | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C20H39N5O7 |
| Mol. mass | 461.55 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Verdamicin is an aminoglycoside antibiotic.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||
